10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Antibiotic Research
Antibiotic research stands at the forefront of combating bacterial infections, a critical endeavor in modern medicine. With the rise of antibiotic-resistant bacteria posing a significant threat to public health, ongoing research aims to develop novel antibiotics and alternative treatment strategies. Scientists are exploring diverse approaches, from traditional drug discovery methods to cutting-edge technologies like machine learning and synthetic biology. Additionally, there's a growing focus on understanding the complex dynamics between bacteria and their environment to develop targeted therapies that minimize collateral damage to beneficial microbes. The urgency of antibiotic research underscores the importance of collaborative efforts among researchers, healthcare professionals, policymakers, and pharmaceutical companies to address this global challenge effectively.
Ranjan Ramasamy
IDFISH Technology, United States
Saurabh Chattopadhyay
University of Kentucky College of Medicine, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Michele Mishto
Francis Crick Institute, United Kingdom
Seki Masafumi
Saitama Medical University International Medical Center, Japan
Chukwuemeka Iloegbu
NYU/Emarin, United States
Stephanie Maltais
University of Montreal, CanadaSubmit your abstract Today
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain